2020
DOI: 10.1371/journal.pone.0240531
|View full text |Cite
|
Sign up to set email alerts
|

Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study

Abstract: Background Clinical inertia can lead to poor glycemic control among type 2 diabetes patients. However, there is paucity of information on clinical inertia in low-and middle-income countries including Malaysia. This study aimed to determine the time to treatment intensification among T2D patients with HbA1c of �7% (�53 mmol/mol) in Malaysian public health clinics. The proportion of patients with treatment intensification and its associated factors were also determined. Material and methods This was a five-year … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 26 publications
0
7
0
Order By: Relevance
“…One of the potential reasons for poor A1C control among our patients is clinical inertia in hyperglycemia management. A study involving this cohort of patients found that the median time to treatment intensification among those with A1C ≥7% was more than 1 year, and only 45% of them had treatment intensification 13 . It was worrying that our patients with the most stringent A1C goal had the worst glycemic control and exhibited the largest decline in A1C performance.…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…One of the potential reasons for poor A1C control among our patients is clinical inertia in hyperglycemia management. A study involving this cohort of patients found that the median time to treatment intensification among those with A1C ≥7% was more than 1 year, and only 45% of them had treatment intensification 13 . It was worrying that our patients with the most stringent A1C goal had the worst glycemic control and exhibited the largest decline in A1C performance.…”
Section: Discussionmentioning
confidence: 85%
“…All patient identifiers were removed after the formation of the cohort dataset 10 . Some results from the analysis of this merged cohort dataset have been published 13 …”
Section: Methodsmentioning
confidence: 99%
“…Clinical inertia-a delay in treatment intensification among patients with poor glycaemic control-was postulated as the primary reason for the A1C increase among their patients 31 . Clinical inertia may also play a role in our cohort as a recent study reported evidence of clinical inertia in the management of T2D patients in Malaysia 32 .…”
Section: Discussionmentioning
confidence: 99%
“…Fourthly, clinical inertia, defined as a delay in treatment intensification among patients with poor glycaemic control, can also explain the suboptimal ABC control (Mata-Cases et al 2016). In support of this possible cause, a recent study in Malaysia has reported evidence of clinical inertia in the management of T2D patients (Wan et al 2020).…”
Section: Attainment Of All Three Abc Goalsmentioning
confidence: 99%